Literature DB >> 311586

Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure.

R P Warrell, M B Hultin, B S Coller.   

Abstract

Factor VIII/von Willebrand factor antigen and von Willebrand factor activity (ristocetin assay) were studied in 12 patients in renal failure. A dramatic increase in both activities was observed (antigen 315 +/- 30 per cent in patients verus 104 +/- 9 per cent in control subjects; activity 402 +/- 48 per cent in patients versus 111 +/- 5 per cent in control subjects; p less than 0.001 for both). Since von Willebrand factor is thought to play at least a facilitative role in the development of arteriosclerosis, these increased activities may contribute to the premature arteriosclerosis reported in patients with chronic renal failure undergoing dialysis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 311586     DOI: 10.1016/0002-9343(79)90531-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

1.  Abnormal factor VIII coagulant antigen in patients with renal dysfunction and in those with disseminated intravascular coagulation.

Authors:  M J Weinstein; L E Chute; G W Schmitt; R H Hamburger; K A Bauer; J H Troll; P Janson; D Deykin
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

2.  Factor VIII related antigen in the assessment of vasculitis.

Authors:  A D Woolf; G Wakerley; T B Wallington; D G Scott; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

3.  Liver function during chronic renal failure in rabbits.

Authors:  E Tvedegaard; H E Poulsen; H Vilstrup; H K Thomsen
Journal:  Experientia       Date:  1984-11-15

4.  Factor VIII complex in uraemia and effects of haemodialysis.

Authors:  J H Turney; H F Woods; M R Fewell; M J Weston
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-23

5.  Coagulation factors as biological risk markers of endothelial dysfunction. Association with the thrombotic episodes of chronic hemodialysis patients.

Authors:  A Sioulis; P Malindretos; A Makedou; P Makris; D Grekas
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

Review 6.  Oral anticoagulant therapy in hemodialysis patients: do the benefits outweigh the risks?

Authors:  Guido Finazzi; Giulio Mingardi
Journal:  Intern Emerg Med       Date:  2009-07-16       Impact factor: 3.397

7.  Exercise induced release of von Willebrand factor: evidence for hypoxic reperfusion microvascular injury in rheumatoid arthritis.

Authors:  A J Farrell; R B Williams; C R Stevens; A S Lawrie; N L Cox; D R Blake
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

8.  Normal and perturbed endothelial cells from canine femoral arteries and femoral veins exhibit heterogeneity in hemostatic properties and growth characteristics.

Authors:  Ni-Hu Tang; Hong-I Chen; Li-Chun Lu; Kenneth M Meyers
Journal:  J Thromb Thrombolysis       Date:  2002-08       Impact factor: 2.300

9.  Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.

Authors:  Alan S Go; Margaret C Fang; Natalia Udaltsova; Yuchiao Chang; Niela K Pomernacki; Leila Borowsky; Daniel E Singer
Journal:  Circulation       Date:  2009-03-02       Impact factor: 29.690

10.  Injury induces increase of von Willebrand factor in rat endothelial cells.

Authors:  M A Reidy; M Chopek; S Chao; T McDonald; S M Schwartz
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.